pulsatilla saponin a has been researched along with Colorectal Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, J; Deng, W; Jia, L; Li, S; Li, W; Si, X; Wu, W; Xu, J; Xu, K; Yang, J; Yin, P; Yu, K; Zhan, Y; Zhang, D | 1 |
Cheng, H; Fan, M; Feng, H; Li, L; Shen, W; Sun, D; Tan, J; Wang, Q; Zhou, T | 1 |
2 other study(ies) available for pulsatilla saponin a and Colorectal Cancer
Article | Year |
---|---|
α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Hypoxia; Mice; Proto-Oncogene Proteins c-akt | 2023 |
α-hederin regulates glucose metabolism in intestinal epithelial cells by increasing SNX10 expression.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Epithelial Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Saponins; Sorting Nexins | 2023 |